2009-12-01
Callosal lesion predicts future attacks after clinically isolated syndrome
Publication
Publication
Neurology , Volume 73 - Issue 22 p. 1837- 1841
BACKGROUND: Current MRI criteria can help predict a second attack after a clinically isolated syndrome (CIS). Given the known association between corpus callosum lesions (CC) and multiple sclerosis (MS), such lesions on MRI could provide additional predictive information. This study assessed whether the presence of CC lesion on MRI could, next to the modified Barkhof criteria, further enhance prediction of conversion from CIS to MS. METHODS: Follow-up study of 158 patients with CIS who underwent MRI after CIS was performed. MRI were scored for the Barkhof criteria and CC lesion. Patients were classified as having MS according to Poser criteria. Cox regression models were used for the time to conversion from CIS to MS. RESULTS: The Barkhof criteria and CC lesion were strongly associated with conversion to MS with hazard ratios (HR), respectively, of 2.6 (95% confidence interval [CI] 1.5-4.3) and 2.7 (95% CI 1.6-4.5). The HRs of CC lesion adjusted for the Barkhof criteria and the Barkhof criteria adjusted for CC lesion were similar (HRs 1.8, not significant). The combined prediction of the Barkhof criteria and CC lesion was 3.3 (95% CI 1.9-5.7). Patients not fulfilling the Barkhof criteria had a fourfold increased risk of MS (HR 3.8, 95% CI 1.5-9.3) when they had a lesion in the CC. CONCLUSIONS: Corpus callosum (CC) lesion and the Barkhof criteria both predicted conversion to multiple sclerosis (MS). When both variables were combined, the association was stronger. The assessment of CC lesion may be a useful additional tool for predicting conversion to MS in patients with clinically isolated syndrome.
Additional Metadata | |
---|---|
doi.org/10.1212/WNL.0b013e3181c3fccf, hdl.handle.net/1765/57422 | |
Neurology | |
Organisation | Department of Neurology |
Jafari, N., Kreft, K., Flach, Z., Janssens, C., & Hintzen, R. (2009). Callosal lesion predicts future attacks after clinically isolated syndrome. Neurology, 73(22), 1837–1841. doi:10.1212/WNL.0b013e3181c3fccf |